Showing results (1841-1850 of 3,947) with videos related to
Sort By:
Pageof 395
Experimental Dermatology|June 11, 2021
A novel mouse model to evaluate neuropeptide Y-mediated melanocyte pathologyZoya T Anderson, Julian Mehl, Katelynn M Corder, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapyP K Buamah, C Cornell, O F James, et al.The Journal of Pharmacy and Pharmacology|May 1, 1988
Differences in the development of tolerance to two anticonvulsant benzodiazepines in the amygdaloid kindled ratN A Young, S J Lewis, Q L Harris, et al.Cancer Research|December 18, 2003
Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma modelIan F Hermans, Tsung Wen Chong, Michael J Palmowski, et al.Cancer Genetics and Cytogenetics|January 22, 2004
Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?Rachel L Harris, Christine J Harrison, Mary Martineau, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Intermittent high-dose tamoxifen as a potential modifier of multidrug resistanceM J Millward, B M Cantwell, E A Lien, et al.Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndromeS L Harris, D W Jones, M J Gallimore, et al.Cell Research|February 10, 2006
Phosphorylated KDR can be located in the nucleus of neoplastic cellsCristina Blazquez, Nathan Cook, Kingsley Micklem, et al.The New England Journal of Medicine|March 18, 1999
Atrial arrhythmia after surgical closure of atrial septal defects in adultsM A Gatzoulis, M A Freeman, S C Siu, et al.Expert Opinion on Drug Metabolism & Toxicology|August 1, 2013
Bioaccessibility of polycyclic aromatic hydrocarbons: relevance to toxicity and carcinogenesisKelly L Harris, Leah D Banks, Jane A Mantey, et al.Pageof 395